TAB1 anticorps (C-Term)
Aperçu rapide pour TAB1 anticorps (C-Term) (ABIN155137)
Antigène
Voir toutes TAB1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- The antibody recognizes TAB1.
-
Purification
- Peptide affinity purified
-
Immunogène
- Synthetic peptide mapping to the C-terminus of human TAB1.
-
-
-
-
Indications d'application
-
Western Blot: 1-4 μg/mL, BaF3 cells can be used as positive controls, A approx. 60 kDa bandshould be detected.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS containing 50 % glycerol, 1 % BSA, and 0.02 % thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- TAB1 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 1 (TAB1))
-
Autre désignation
- TAB1 / MAP3K7IP1
-
Sujet
- TAB1 (TAK1 binding protein 1) is an adaptor protein that can activate TAK1 in vivo through phosphorylation of TAK1, a mitogen-activated protein kinase kinase kinase. Once activated TAK1 phosphorylates MAPK kinase MKK4 and MKK3/6, which activate p38 MAPK and JNK, respectively.Synonyms: Mitogen-activated protein kinase kinase kinase 7-interacting protein 1, TAK1-binding protein 1, TGF-beta-activated kinase 1-binding protein 1
-
ID gène
- 10454
-
NCBI Accession
- NP_006107
-
UniProt
- Q15750
-
Pathways
- Signalisation TLR, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades
Antigène
-